Skip to main content
PAXH
OTC Technology

PREAXIA 10-Q Reveals Zero Revenue, $(0.02) EPS Amid Continued Product Development

feedReported by Wiseek News
Sentiment info
Negative
Importance info
7
Price
$0.22
Mkt Cap
$4.349M
52W Low
$0.008
52W High
$2.5
Market data snapshot near publication time

summarizeSummary

PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) filed its 10-Q, reporting no revenue for the three and six months ended November 30, 2025. The company posted a net loss of $(0.857) million for the six-month period, resulting in an EPS of $(0.02). This filing confirms the micro-cap company's pre-revenue status and ongoing operational losses as it continues to invest in research and development for its AI-driven personal finance 'super-app'. Investors will be closely watching for updates on the planned initial launch in Canada and any future signs of revenue generation.

At the time of this announcement, PAXH was trading at $0.22 on OTC in the Technology sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.01 to $2.50. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed PAXH - Latest Insights

PAXH
Apr 21, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
9
PAXH
Apr 21, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
7
PAXH
Apr 21, 2026, 4:44 PM EDT
Filing Type: 10-Q
Importance Score:
9
PAXH
Mar 05, 2026, 4:28 PM EST
Filing Type: 8-K/A
Importance Score:
9
PAXH
Feb 25, 2026, 9:25 PM EST
Filing Type: 8-K
Importance Score:
9